In the current investigation, we used LC3 shRNA plasmid transfection for inhibition of expression of LC3 mRNA leading to low levels of both LC3 I and LC3 II in human malignant neuroblastoma SN-N-BE2 and IMR-32 cell lines. The gene discussed is MAP1LC3A; the disease is neuroblastoma.